Literature DB >> 24687697

Patient and process factors associated with all-cause 30-day readmission among patients with heart failure.

Beth D Whittaker1, Laurie A Soine, Kathleen M Errico.   

Abstract

PURPOSE: To explore the patient and process factors associated with all-cause 30-day readmission after heart failure (HF) hospitalization and develop recommendations to reduce readmissions of patients with HF. DATA SOURCES: A retrospective, cohort study of 239 patients ages 18 years and older was performed using electronic medical chart review. All patients were discharged from the medical center between July 1, 2009 and June 30, 2010 with a principal diagnosis of HF. Patient and process factors were compared in readmitted and non-readmitted groups.
CONCLUSIONS: Renal failure/insufficiency was the only factor significantly associated with all-cause 30-day readmission among patients with HF. IMPLICATIONS FOR PRACTICE: Assessment of renal function during hospitalization will help identify patients with HF at high risk for all-cause 30-day readmission. Give careful consideration to the timing of discharge of patients who appear otherwise ready for discharge but still have creatinine levels above their baseline. Careful follow-up is needed for patients with impaired renal function. ©2014 American Association of Nurse Practitioners.

Entities:  

Keywords:  Heart failure; adults; cardiac; cardiology; hospital readmission

Mesh:

Year:  2014        PMID: 24687697     DOI: 10.1002/2327-6924.12123

Source DB:  PubMed          Journal:  J Am Assoc Nurse Pract        ISSN: 2327-6886            Impact factor:   1.165


  2 in total

1.  Screening echocardiograms in a senior focused value based primary care improves systolic heart failure detection and clinical management.

Authors:  Reyan Ghany; Leonardo Tamariz; Gordon Chen; Alina Ghany; Emancia Forbes; Thiago Tajiri; Ana Palacio
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

Review 2.  Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis.

Authors:  Tian Lan; Yan-Hui Liao; Jian Zhang; Zhi-Ping Yang; Gao-Si Xu; Liang Zhu; Dai-Ming Fan
Journal:  Ther Clin Risk Manag       Date:  2021-12-07       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.